- Autores: Paula J. Gómez‑González, João Perdigão, Pedro Gomes, Zully M. Puyen, David Santos‑Lazaro, Gary Napier, Martin L. Hibberd, Miguel Viveiros, Isabel Portugal, Susana Campino, Jody E. Phelan, Taane G. Clark
- Ano de Publicação: 2021
- Journal: Scientific Reports
- Link: https://doi.org/10.1038/s41598-021-98862-4
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the deadliest infectious diseases worldwide. Multidrug and extensively drug‑resistant strains are making disease control difficult, and exhausting treatment options. New anti‑TB drugs bedaquiline (BDQ), delamanid (DLM) and pretomanid (PTM) have been approved for the treatment of multi‑drug resistant TB, but there is increasing resistance to them. Nine genetic loci strongly linked to resistance have been identified (mmpR5, atpE, and pepQ for BDQ; ddn, fgd1, fbiA, fbiB, fbiC, and fbiD for DLM/PTM). Here we investigated the genetic diversity of these loci across >33,000 M. tuberculosis isolates. In addition, epistatic mutations in mmpL5-mmpS5 as well as variants in ndh, implicated for DLM/PTM resistance in M. smegmatis, were explored. Our analysis revealed 1,227 variants across the nine genes, with the majority (78%) present in isolates collected prior to the roll‑out of BDQ and DLM/PTM. We identified phylogenetically‑related mutations, which are unlikely to be resistance associated, but also high‑impact variants such as frameshifts (e.g. in mmpR5, ddn) with likely functional effects, as well as non‑synonymous mutations predominantly in MDR‑/XDR ‑TB strains with predicted protein destabilising effects. Overall, our work provides a comprehensive mutational catalogue for BDQ and DLM/PTM associated genes, which will assist with establishing associations with phenotypic resistance; thereby, improving the understanding of the causative mechanisms of resistance for these drugs, leading to better treatment outcomes.
Bacterial genes; Genetics; Microbial genetics.
Reference (AMA 11 style)
Gómez‑González PJ, Perdigão J, Gomes P, Puyen ZM, et al. Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid. Sci Rep. 2021;11, 19431. https://doi.org/10.1186/s12913-021-06389-1
Reference (APA 7 style)
Gómez‑González, P. J, Perdigão. J, Gomes P., Puyen, Z. M., Santos‑Lazaro, D., Napier, G., Hibberd, M. L., Viveiros, M., Portugal, I., Campino, S., Phelan, J. E., Clark, T. G., & Martins, M.R.O. (2021). Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid. Scientific Reports 11, 19431. https://doi.org/10.1186/s12913-021-06389-1